The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia

Cell Mol Neurobiol. 2022 Nov;42(8):2459-2472. doi: 10.1007/s10571-021-01133-z. Epub 2021 Aug 12.

Abstract

Epigenetics play an essential role in the occurrence and improvement of many diseases. Evidence shows that epigenetic modifications are crucial to the regulation of gene expression. DNA methylation is closely linked to embryonic development in mammalian. In recent years, epigenetic drugs have shown unexpected therapeutic effects on neurological diseases, leading to the study of the epigenetic mechanism in neurodegenerative diseases. Unlike genetics, epigenetics modify the genome without changing the DNA sequence. Research shows that epigenetics is involved in all aspects of neurodegenerative diseases. The study of epigenetic will provide valuable insights into the molecular mechanism of neurodegenerative diseases, which may lead to new treatments and diagnoses. This article reviews the role of epigenetic modifications neurodegenerative diseases with dyskinesia, and discusses the therapeutic potential of epigenetic drugs in neurodegenerative diseases.

Keywords: Epigenetic; Motor dysfunction; Nervous system; Neurodegeneration; Parkinson’s disease.

Publication types

  • Review

MeSH terms

  • Animals
  • DNA Methylation / genetics
  • Dyskinesias* / genetics
  • Epigenesis, Genetic
  • Humans
  • Mammals
  • Neurodegenerative Diseases* / genetics